NCT06099106View on ClinicalTrials.gov

Safety and Performance of ENDOMATIC SEPIOLA Left Atrial Appendage (LAA) Closure Device

NARecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

May 31, 2027

Conditions
Atrial Fibrillation
Interventions
DEVICE

SEPIOLA System

Implantation of the SEPIOLA device into the left atrial appendage.

Trial Locations (5)

0112

COMPLETED

Israeli-Georgian Medical Research Clinic Helsicore, Tbilisi

0159

COMPLETED

Tbilisi Heart and Vascular Clinic, Tbilisi

Unknown

RECRUITING

Vilnius university hospital Santaros Klinikos, Vilnius

RECRUITING

Uniwersytecki Szpital Kliniczny w Poznaniu, Poznan

RECRUITING

Ezgu Niyat, Tashkent

All Listed Sponsors
lead

Endomatic Ltd.

INDUSTRY